Abivax (ABVX) Goodwill & Intangibles (2021 - 2026)
Abivax's (ABVX) quarterly Goodwill & Intangibles came in at $29.3 million in Q1 2026, up 11.3% year-on-year from $26.3 million in Q1 2025, and up 0.58% quarter-over-quarter from $29.1 million in Q4 2025.
Abivax (ABVX) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Abivax's Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $29.3 million for Q1 2026.
- On a quarterly basis, Goodwill & Intangibles rose 11.3% year-over-year to $29.3 million in Q1 2026; TTM through Mar 2026 was $29.3 million, a 11.3% increase from a year earlier, with the FY2025 full-year figure at $29.1 million, up 7.54% from the prior year.
- Goodwill & Intangibles improved to $29.3 million in Q1 2026 per ABVX's latest filing, from $29.1 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $29.3 million in Q1 2026 and bottomed at -$3294.7 in Q3 2024.
- The 5-year median for Goodwill & Intangibles is $26.9 million (2023), against an average of $24.8 million.
- Across the five-year window, Goodwill & Intangibles tumbled 30.46% in 2022 and jumped 888070.74% in 2025, its largest moves.
- Year by year, Goodwill & Intangibles stood at $25.5 million in 2022, then climbed by 5.45% to $26.9 million in 2023, then declined by 0.67% to $26.7 million in 2024, then rose by 8.93% to $29.1 million in 2025, then gained by 0.58% to $29.3 million in 2026.
- Per Business Quant, the three latest ABVX Goodwill & Intangibles figures stand at $29.3 million (Q1 2026), $29.1 million (Q4 2025), and $29.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.30 Mn |
| Dec 31, 2025 | 29.13 Mn |
| Sep 30, 2025 | 29.26 Mn |
| Jun 30, 2025 | 28.33 Mn |
| Mar 31, 2025 | 26.32 Mn |
| Dec 31, 2024 | 26.74 Mn |
| Sep 30, 2024 | -3,294.66 |
| Jun 30, 2024 | 26.95 Mn |
| Dec 31, 2023 | 26.92 Mn |
| Dec 31, 2022 | 25.53 Mn |
| Dec 31, 2021 | 36.72 Mn |